Eyebright Medical Technology Beijing Co Ltd (688050) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Eyebright Medical Technology Beijing Co Ltd (688050) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥76.92 Million ≈ $11.26 Million USD) by net assets (CN¥3.01 Billion ≈ $440.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 688050 market cap overview for the company's overall valuation and market capitalisation.
Eyebright Medical Technology Beijing Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Eyebright Medical Technology Beijing Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Eyebright Medical Technology Beijing Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eyebright Medical Technology Beijing Co Ltd ranked by their cash flow conversion efficiency. Explore 688050 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhongnanhong Culture Group Co Ltd
SHE:002445
|
0.032x |
|
Service Stream Ltd
AU:SSM
|
0.101x |
|
PORR AG
VI:POS
|
0.060x |
|
Hunan Changgao High Voltage Switchgear Group Co Ltd
SHE:002452
|
0.057x |
|
Hotel101 Global Holdings Corp. Class A Ordinary Shares
NASDAQ:HBNB
|
N/A |
|
Bombay Burmah Trading Corporation Limited
NSE:BBTC
|
0.039x |
|
Bowhead Specialty Holdings Inc.
NYSE:BOW
|
0.198x |
|
Blue Jet Healthcare Limited
NSE:BLUEJET
|
0.152x |
Annual Cash Flow Conversion Efficiency for Eyebright Medical Technology Beijing Co Ltd (2016–2025)
The table below shows the annual cash flow conversion efficiency of Eyebright Medical Technology Beijing Co Ltd from 2016 to 2025. View Eyebright Medical Technology Beijing Co (688050) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.97 Billion ≈ $434.64 Million |
CN¥369.15 Million ≈ $54.02 Million |
0.124x | -5.86% |
| 2024-12-31 | CN¥2.63 Billion ≈ $385.47 Million |
CN¥347.75 Million ≈ $50.89 Million |
0.132x | +37.45% |
| 2023-12-31 | CN¥2.36 Billion ≈ $344.75 Million |
CN¥226.27 Million ≈ $33.11 Million |
0.096x | -26.27% |
| 2022-12-31 | CN¥1.92 Billion ≈ $280.98 Million |
CN¥250.13 Million ≈ $36.60 Million |
0.130x | +3.37% |
| 2021-12-31 | CN¥1.74 Billion ≈ $254.64 Million |
CN¥219.30 Million ≈ $32.09 Million |
0.126x | +58.11% |
| 2020-12-31 | CN¥1.55 Billion ≈ $226.47 Million |
CN¥123.35 Million ≈ $18.05 Million |
0.080x | +2.21% |
| 2019-12-31 | CN¥647.52 Million ≈ $94.75 Million |
CN¥50.49 Million ≈ $7.39 Million |
0.078x | +35.73% |
| 2018-12-31 | CN¥553.87 Million ≈ $81.05 Million |
CN¥31.82 Million ≈ $4.66 Million |
0.057x | +174.70% |
| 2017-12-31 | CN¥198.44 Million ≈ $29.04 Million |
CN¥4.15 Million ≈ $607.32K |
0.021x | +216.46% |
| 2016-12-31 | CN¥187.52 Million ≈ $27.44 Million |
CN¥-3.37 Million ≈ $-492.75K |
-0.018x | -- |
About Eyebright Medical Technology Beijing Co Ltd
Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internationally. The company offers intraocular, trimmers, capsular tension ring, defocus lense, orthokeratology, and contact lenses in the areas of surgical treatment, myopia management, and consumer vision care. It also provides solutions for opht… Read more